Developing and improving models for testing new treatments for kids with cancer

Brain and spine tumors are one of the most common forms of cancer found in kids, second only to leukemia. Despite significant advances in treatment, brain tumors remain the leading cause of cancer-related death in children. The kids who do survive often suffer from long-term side effects from treatment, and face the risk of recurrence…


2022 Research Funded

Thanks to the support of generous donors, 28 projects have received funding for 2022. These projects address the widest range of pediatric cancers and represent the largest single-year financial support in the history of The Morgan Adams Foundation. This groundbreaking research has the potential to change the landscape for kids with cancer. The projects are…


Five new clinical trials for kids with cancer

Progress in medical research takes time – and requires sustained funding. Support for kids’ cancer research is critically important. Donations from caring individuals make possible studies into safer and more effective treatments for kids and teens. Without donor generosity, the good ideas doctors and researchers have would never make it out of the lab and into…


The evolution of genetic sequencing: from “chips” to RNA sequencing and single-cell analysis

Andrew Donson, Senior Research Associate The Morgan Adams Foundation Pediatric Brain Tumor Research Program at the University of Colorado Anschutz Medical Campus & Children’s Hospital Colorado Andy Donson has been an integral member of the research team since the lab first opened its doors more than 25 years ago. “I was a biochemistry major in…


Research identifies ‘genetic switch’ that may protect brain cancer stem cells

Chemotherapy and radiation kill rapidly dividing cells, a hallmark of cancer (and hair). However, cancer stem cells do not divide rapidly and so tend to resist these treatments. And while these stem cells make up only a small percentage of a tumor’s bulk, if only a small population survives treatment, they can often regrow a…


MAF Researchers secure federal grants and publication

There was quite a lot for researchers in the Morgan Adams Foundation Brain Tumor Research Program to celebrate in February! Dr. Nick Foreman’s group was awarded TWO large federal grants to continue their industry-leading research of ependymoma. First, an RO1 from the National Institutes of Health (NIH) / National Cancer Institute (NCI) will support an…


International collaboration enables MAF researchers to apply for grant worth $9.6 million

Nick Foreman, MD, the Seebaum-Tschetter Chair of Pediatric Neuro-Oncology at Children’s Hospital Colorado, has been leading the way in moving groundbreaking kids’ cancer research from the lab to the clinic in Colorado for more than two decades.  Dr. Foreman’s prescient decision to collect and store tumor samples means the Morgan Adams Foundation Pediatric Brain Tumor…


Newsletter Fall 2017 Page 2